BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents. 2019

Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Natural Products Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, Telangana, India.

A series of novel 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives have been synthesized in good to excellent yields. Through the copper-catalyzed azide-alkyne cycloaddition via reaction of 7-(prop-2-ynyl)-7H-pyrrolo[2,3-d]pyrimidine and aryl, heteroaryl and alkyl azides in the presence of CuSO4·5H2O and sodium ascorbate. These compounds were evaluated for their in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv strain. Most of these pyrrolopyrimidine-triazole hybrids exhibited good anti tubercular activity. The antimycobacterial assay results showed that the minimum inhibitory concentration of compounds 4q and 4r were 0.78 µg/mL. The molecular docking results also had shown highest Moldock score for same compounds. These novel compounds exhibited good inhibition activities and further structure-activity studies of the derivatives had shown promising features to use in antitubercular therapy.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents.
August 2017, Bioorganic & medicinal chemistry letters,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Synthesis and biological evaluation of phenyl-1H-1,2,3-triazole derivatives as anti-inflammatory agents.
April 2015, Bioorganic chemistry,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Novel pyrimidine-2,4-dione-1,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation.
January 2017, European journal of medicinal chemistry,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Synthesis and evaluation of novel 7H-pyrrolo-[2,3-d]pyrimidine derivatives as potential anticancer agents.
May 2019, Future medicinal chemistry,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation.
May 2018, RSC advances,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents.
February 2007, Bioorganic chemistry,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents.
December 2019, European journal of medicinal chemistry,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation.
November 2020, European journal of medicinal chemistry,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Design, synthesis and biological evaluation of novel 4-(pyrrolo[2,3-d]pyrimidine-4-yloxy)benzamide derivatives as potential antitumor agents.
February 2021, Bioorganic & medicinal chemistry letters,
Kasa Shiva Raju, and Sandeep AnkiReddy, and Gowravaram Sabitha, and Vagolu Siva Krishna, and Dharmarajan Sriram, and Kunduru Bharathi Reddy, and Someswar Rao Sagurthi
Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrrolo[2,3-b]pyridine derivatives as potential anti-tumor agents.
January 2020, Bioorganic chemistry,
Copied contents to your clipboard!